Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance

BACKGROUND: The loss of chloroquine (CQ) effectiveness has led to its withdrawal from national policies as a first-line treatment for uncomplicated malaria in several endemic countries, such as the Democratic Republic of Congo (DRC). The K76T mutation on the pfcrt gene has been identified as a marke...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Malar J
Auteurs principaux: Yobi, Doudou M., Kayiba, Nadine K., Mvumbi, Dieudonné M., Boreux, Raphael, Kabututu, Pius Z., Situakibanza, Hippolyte N. T., Likwela, Joris L., De Mol, Patrick, Okitolonda, Emile W., Speybroeck, Niko, Mvumbi, Georges L., Hayette, Marie-Pierre
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7085146/
https://ncbi.nlm.nih.gov/pubmed/32197607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-020-03192-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires